← Upcoming Courses
The Cardio-Renal Metabolic (CRM) 360 Webinar 2 is a virtual Continuing Professional Development (CPD) training program designed to enhance clinical understanding and practical application in the management of Cardio-Renal Metabolic conditions. This educational experience will deliver high-value insights into the intricate and interdependent relationship between the heart, kidneys, and metabolic system—critical knowledge for clinicians managing patients with comorbidities such as diabetes, hypertension, cardiovascular disease, and renal dysfunction.
The growing burden of cardiovascular, renal, and metabolic diseases presents a significant challenge to healthcare systems worldwide. Increasing evidence demonstrates that these conditions are closely interconnected, with dysfunction in one organ system often contributing to the progression of disease in the others. This interconnected relationship, commonly referred to as Cardio-Renal-Metabolic (CRM) Disorder, requires a comprehensive and integrated approach to patient care.
This Continuing Professional Development (CPD) session is designed to enhance healthcare professionals' understanding of the complex interactions between cardiovascular disease, chronic kidney disease, and metabolic disorders such as type 2 diabetes. Participants will explore the pathophysiological links that underpin CRM disorders and examine the importance of early identification, risk stratification, and coordinated management strategies to improve patient outcomes.
The session will also highlight emerging evidence and current clinical recommendations regarding the role of empagliflozin in the management of CRM patients. Participants will gain insights into the benefits of empagliflozin across cardiovascular, renal, and metabolic outcomes, as well as practical considerations for its appropriate use in clinical practice.
Learning Objectives
By the end of this session, participants will be able to:
- Describe the interrelationship between cardiovascular, renal, and metabolic diseases.
- Recognize the impact of CRM disorders on patient morbidity and mortality.
- Identify patients at risk of developing cardio-renal-metabolic complications.
- Discuss evidence-based approaches to the early management of CRM disorders.
- Evaluate the role of empagliflozin in reducing cardiovascular and renal risk while supporting metabolic control.
- Apply current clinical evidence to optimize patient-centred care for individuals living with CRM disorders.
This virtual CPD event provides an opportunity for healthcare professionals to strengthen their knowledge of integrated disease management and explore practical strategies for improving outcomes in patients affected by cardio-renal-metabolic disorders. Highlights include a high-level panel discussion, interactive Q&A sessions, and focused topic presentations including:
i. Cardio-Renal-Metabolic Disorder: Understanding the interconnected Link
ii. Early Management Strategies for CRM patients—Role of Empagliflozin
WHY YOU SHOULD ATTEND
This webinar is essential for all healthcare professionals engaged in chronic disease management and integrated patient care. The growing complexity of CRM conditions requires up-to-date clinical knowledge and therapeutic agility. Participants will gain access to cutting-edge evidence, clinical guidelines, and real-world insights that are directly applicable to patient care. Whether you are a General Practitioner, Family Physician, Physician Specialist, or Cardiologist, this session will equip you with the tools and knowledge needed to make informed, patient-centered decisions across multiple specialties.
PROUDLY SPONSORED BY
This is a virtual event scheduled for Friday the 19th of June, 2026 at 15:30 GMT.
Target Audience: Medical Doctors
Moderator: Dr Akrem Y M Elmalti
Date: Friday, 19th June, 2026
Time: 15:30 GMT (3:30 PM Local Time)
Don’t miss out on this exciting opportunity to elevate your skills and make a lasting impact CRM!
Overview
Course Description
This upcoming virtual CPD training event will delve into the complex interconnections between the cardiovascular, renal, and metabolic systems, offering healthcare professionals the opportunity to deepen their understanding of how these systems influence patient outcomes. Facilitated by distinguished experts, the session will explore critical topics such as decoding the nexus between Heart-Kidney-Pancreas for patient wellbeing and application of Empagliflozin in CRM disease management. Attendees will gain valuable insights into diabetic guidelines, clinical practice gaps, and strategies for selecting appropriate medications tailored to patients' needs. With interactive Q&A and a panel discussion, this event provides an exciting opportunity for GPs, Family Physicians, Pharmacists, Physician Specialists, and Cardiologists to enhance their knowledge and improve clinical practices in managing CRM conditions.
What you will learn
By the end of this CPD training, participants should be able to:
1. Explain the physiological and clinical interconnection between the cardiovascular, renal, and metabolic systems.
2. Identify current clinical guidelines and practice gaps in the management of Cardio-Renal Metabolic diseases, especially in diabetic patients.
3. Analyze and interpret evidence supporting the use of Empagliflozin as a multi-benefit agent in CRM management.
4. Apply patient-specific therapeutic strategies for selecting medications to optimize clinical outcomes in CRM conditions.
5. Discuss emerging trends, challenges, and future directions in the holistic management of Cardio-Renal Metabolic syndromes.
Course Content
Lecture Sessions
- LIVE EVENT: Friday 19th June, 2026 @ 15:30 GMT (3:30 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
About Facilitators
- 2 Courses on CES
Dr. Sarah Jarvis
MA (Cantab), BM, BCh (Oxon), DRCOG, FRCGP, MBE
Clinical Consultant | GP Locum
Patient.info | Richford Gate Medical Practice, London
Dr. Sarah Jarvis is a highly experienced General Practitioner, medical broadcaster, author, and clinical consultant. Over the course of her career, she has combined frontline clinical work with influential roles in public education and media.
View full profile / courses
- 3 Courses on CES
Dr. Peter Lin
MD, CCFP
Specialty Primary Care Physician
Canadian Heart Research Centre, Toronto, ON, Canada
Peter Lin is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and is a lecturer and speaker at two busy family practices in Toronto. He started his studies in the Faculty of Science and Engineering at the University of Toronto.
View full profile / courses
